SCHEMBL3565185

SCHEMBL3565185

O=C(O)c1ccc2[nH]c(-c3ccc(C(=O)c4ccc5c(c4)OCCO5)cc3)nc2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK2 O96017 6/20 0.69
▸ HDAC6 Q9UBN7 1/20 0.53
▸ MAPT P10636 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.49
▸ SRD5A2 P31213 1/20 0.49
▸ NR4A2 P43354 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ NPC1 O15118 1/20 0.47
▸ NRP1 O14786 2/20 0.47
▸ MMP2 P08253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3567003 0.90 CHEK2 (0.84) CHEK2HDAC6
SCHEMBL3570736 0.86 CHEK2 (0.70) CHEK2HDAC6MAPTKDM4EKMT2A
SCHEMBL3562405 0.85 CHEK2 (0.71) CHEK2HDAC6MAPTKDM4EKMT2A
SCHEMBL1378452 0.83 CHEK2 (0.84) CHEK2MAPTKDM4EKMT2ARAB9A
SCHEMBL5178851 0.83 CHEK2 (0.67) CHEK2HDAC6MAPTKDM4EKMT2A
SCHEMBL3560621 0.82 KDM4E (0.66) CHEK2HDAC6KDM4EKMT2ARAB9A
SCHEMBL28930292 0.82 KDM4E (0.68) CHEK2HDAC6KDM4EKMT2ARAB9A
SCHEMBL7602620 0.80 KDM4E (0.70) CHEK2KDM4EKMT2ARAB9ANR4A2
SCHEMBL3570845 0.80 CHEK2 (0.72) CHEK2KDM4EKMT2AMEN1NR4A2
SCHEMBL3565165 0.80 CHEK2 (0.64) CHEK2KDM4EKMT2ARAB9ANR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687639-B2 Substituted benzimidazoles and imidazo-[4,5]-pyridines JANSSEN PHARMACEUTICA N.V. (BE) 2010-03-30 — — US disclosed
US-20060252793-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines BW CONVERTING AB (SE) 2006-11-09 — — US disclosed
US-7132440-B2 Substituted benzimidazoles and imidazo-[4,5]-pyridines JANSSEN PHARMACEUTICA, N.V. (BE) 2006-11-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252793-A1 Substituted benzimidazoles and imidazo-[4,5]-pyridines CDKN1A, DDB1, TMBIM6 CHEK2 14/4885HDAC6 1636/4885MAPT 4562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback